48,531 Shares in Astera Labs, Inc. $ALAB Bought by EULAV Asset Management

Key Points

• EULAV Asset Management acquired 48,531 Astera Labs shares worth approximately $17.3 million in the third quarter. Institutional investors collectively own 60.47% of the company.
• Astera Labs reported strong quarterly results, with revenue rising 104.5% year over year to $392.4 million and EPS of $0.80, exceeding analyst estimates.
• Analyst sentiment remains positive but mixed: the stock has a “Moderate Buy” consensus rating and a $340.79 average price target, while insiders have sold 408,558 shares worth $127.3 million over the past 90 days.

EULAV Asset Management acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 48,531 shares of the company's stock, valued at approximately $17,275,000.

A number of other hedge funds have also modified their holdings of the business. BlackRock Inc. acquired a new position in shares of Astera Labs in the 2nd quarter valued at $6,609,581,000. Atreides Management LP boosted its stake in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Van ECK Associates Corp boosted its stake in Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock worth $1,080,980,000 after purchasing an additional 373,545 shares during the period. Bank of America Corp DE acquired a new stake in Astera Labs during the 2nd quarter worth $1,061,791,000. Finally, Amundi boosted its stake in Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company's stock worth $206,139,000 after purchasing an additional 823,477 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan Dyckerhoff sold 8,994 shares of the firm's stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the sale, the director owned 3,309 shares in the company, valued at $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 408,558 shares of company stock worth $127,306,034. Company insiders own 10.40% of the company's stock.

Astera Labs Price Performance

Astera Labs stock opened at $257.16 on Monday. The stock's 50 day moving average price is $310.54 and its 200 day moving average price is $304.08. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market cap of $44.61 billion, a PE ratio of 127.31 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the prior year, the business posted $0.44 earnings per share. Astera Labs's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Morgan Stanley upped their target price on shares of Astera Labs from $240.00 to $335.00 and gave the company an "overweight" rating in a report on Monday, August 3rd. Citigroup downgraded shares of Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday, October 9th. UBS Group reiterated a "neutral" rating and set a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Zacks Research lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, October 5th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.